Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksQLINE
analysis
QLINE
569.00-3.5 (-0.60%)
22 Oct, 12:00 AM

Summary Recommendation

A summary recommendation on the stock based on our classification and scoring techniques along with analyst recommendations.

StyleBoxTMWhat is StyleBox?

Neutral

This stock could not be classified into any of the StyleBoxes and hence a neutral stance.

Detail >
QVM scoreWhat is QVM score?
Score not available. Market cap may be < ₹100 Cr or data unavailable.
Analyst ratingWhat is Analyst rating?
No active sell-side coverage. Recommendations not available.
Technical indicatorsSee all >

13 %

Q-Line Biotech Ltd. on 1D timeframe is bullish for 3 out of 23 technical oscillators and moving averages.

Ratios and Statistics

A look at some key ratios and statistics for the stock. Change tabs to find the relevant ratios. Click on chart icon to view historical analysis of a particular ratio.

Historical Performance

Performance with respect to benchmark. Prices are adjusted for splits, bonus and rights issue.

Show dividend adjusted performance
NIFTY50
NIFTYHEALTHCARE
Add benchmark
Note: Prices are adjusted for splits, bonus and rights issue.

Showing:

Performance summary
QLINENIFTY50NIFTYHEALTHCARE
Start Period29 May 202629 May 202629 May 2026
End Period22 Oct 202622 Oct 202622 Oct 2026
Cumulative Return19.89%-3.65%0.8%
CAGR58.89%-9.06%2.04%
Volatility (ann.)49.08%11.62%12.23%
Max Drawdown -21.65%-10.26%-8.47%
RoMaD 2.72%-0.88%0.24%
Sharpe1.09-1.09-0.1
Sortino1.8-1.5-0.13
Sortino/√21.27-1.06-0.09

Scores on value, momentum and quality parameters. Change tabs to compare across market, sector, industry.

Value score

0.0 / 100

↓

Q-Line Biotech Ltd. is overvalued relative to other stocks in the market

What is Value score?
Momentum score

21.0 / 100

↓

Q-Line Biotech Ltd. has low momentum relative to other stocks in the market

What is Momentum score?
Quality score
Score not available.
QVM score
Score not available.

A comprehensive scorecard to compare Q-Line Biotech Ltd. on all metrics with other stocks. Access both rank and scores.

Value
Market
(All Stocks in NSE)
Sector
(Healthcare)
Industry Group
(Healthcare Equipment & Supplies)
Industry
(Medical Equipment & Supplies)
Size and Listing
Market Cap
1,327 Cr
Liquidity
Avg daily turnover 1M
5 Cr
Avg daily volume 1M
85,333
Avg daily turnover 3M
6 Cr
Avg daily volume 3M
97,829
Bid Ask Spread
0.18%
Delivery Percentage
80.28%
Volume surge ratio
0.90
Ownership
DII Holding %
2.61%
QoQ change DII holding %
2.61%
FII Holding %
1.67%
QoQ change FII holding %
1.67%
QoQ change Gov holding %
0.00%
Promoter holding %
67.51%
QoQ change Promoter holding %
0.00%
Promoter pledged %
0.00%
Retail Holding %
20.50%
QoQ change Retail holding %
20.50%

Analyse how the stock fares on some investment checklists created by legendary investors and gurus. Also, build your own custom checklist.

O'Shaughnessy Tiny Titans
Benjamin Graham's Value
Piotroski F-Score
Dreman contrarian value
Peter Lynch Growth/Value
O'Shaugnessy Value
Templeton Growth/Value
Warren Buffet’s Consistent Compounders
John Neff’s contrarian value
Richard Driehaus Momentum Strategy
O'Shaughnessy Tiny Titans
1
Created by the famous investor James O'Shaugnessy, this screen/checklist aims to find out small-cap stocks with significant growth potential. We look for companies with market capitalization between Rs 500 cr and Rs 1500 cr that are reasonable valued and are in the top 25 percentile momentum as measured by Momentum score.

40.0 / 100

Q-Line Biotech Ltd. passes 2 out of 5 of this checklist's rules
Hits
Misses

Frequently Asked Questions

What is the PB ratio of Q-Line Biotech Ltd.?
The Price-to-Book (PB) ratio of Q-Line Biotech Ltd. is -. It compares the stock's market price to its book value per share.
What is the EV/EBITDA of Q-Line Biotech Ltd.?
The EV/EBITDA of Q-Line Biotech Ltd. is -. This ratio is used to assess the overall value of a company relative to its earnings before interest, taxes, depreciation and amortisation.
What is the debt-to-equity ratio of Q-Line Biotech Ltd.?
The debt-to-equity (D/E) ratio of Q-Line Biotech Ltd. is -. A lower D/E ratio generally indicates a more financially stable company with less leverage.
What is the promoter holding in Q-Line Biotech Ltd.?
Promoters hold 67.51% of Q-Line Biotech Ltd. shares as per the latest quarterly shareholding disclosure.
What is the operating profit margin of Q-Line Biotech Ltd.?
The operating profit margin of Q-Line Biotech Ltd. is -, reflecting how much profit the company earns from its core operations relative to revenue.
What is the net profit margin of Q-Line Biotech Ltd.?
The net profit margin of Q-Line Biotech Ltd. is available in the Income Statement section of the Statements tab.
What is the Sharpely score for Q-Line Biotech Ltd.?
On Sharpely's proprietary scoring system, Q-Line Biotech Ltd. has a Quality Score of -/100, Value Score of 0/100 and Price Momentum Score of 20/100. , value is low and price momentum is low. Visit the Scorecard and Checklist sections on the Analysis tab for a full breakdown.